Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Rosenbaum et al

Affiliations

• ¹ Centre for Epidemiology Versus Arthritis, The University of Manchester, Manchester, UK.
• ² National Institute for Health Research (NIHR) Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK.
• ³ Epidemiology and Health Care Research, German Rheumatism Research Center Berlin (DRFZ Berlin), Berlin, Germany.
• ⁴ Instituto de Salud Musculoesquelética, Madrid, Spain.
• ⁵ Institut Pierre Louis d'Epidémiologie et de Santé Publique, INSERM, Sorbonne Université, Paris, France.
• ⁶ Department of Rheumatology, Pitié-Salpêtrière Hospital, AP-HP.Sorbonne Université, Paris, France.
• ⁷ Portuguese League Against Rheumatic Diseases (LPCDR), Lisbon, Portugal.
• ⁸ Standing Committee of People with Arthritis/Rheumatism in Europe (PARE), European Alliance of Associations for Rheumatology (EULAR), Kilchberg, Switzerland.
• ⁹ Department of Medicine, Division of Rheumatology, University of California San Francisco, San Francisco, California, USA.
• ¹⁰ Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
• ¹¹ Metro North Hospital & Health Service, Royal Brisbane and Woman's Hospital Health Service District, Brisbane, Queensland, Australia.
• ¹² Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, UK p.machado@ucl.ac.uk.
• ¹³ National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.
• ¹⁴ Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK.